Artiva Biotherapeutics, Inc. ARTV
6.99
(0.50)
(6.68%)
as of 25 Sep
- Market cap
- $366.2M
- P/E
- 0.0×
Follow ARTV
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
23.97 | 7.98 | 8.26 | 11.07 | |
Current Ratio |
24.16 | 8.16 | 8.61 | 11.65 | |
Net Debt/EBITDA |
13.34 | 3.65 | 5.08 | 5.53 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.81 | 0.89 | 0.71 | 0.89 | |
Capex/Depreciation |
(0.60) | (0.36) | (0.63) | (0.91) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.52) | (0.85) | (0.60) | (0.78) | |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.02) | |
Free Cash Flow per Share |
(0.53) | (0.86) | (0.62) | (0.81) | |
Cash per Share |
8.86 | 3.52 | 4.42 | 5.02 | |
Shareholders Equity per Share |
8.82 | 3.56 | 4.50 | 5.28 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.82 | 3.56 | 4.50 | 5.28 | |
Free Cash Flow |
(20.77) | (21.19) | (15.15) | (19.80) | |
Working Capital |
337.70 | 77.86 | 99.58 | 118.41 | |
Capital Expenditures |
(0.41) | (0.24) | (0.42) | (0.60) | |
Net Current Asset Value |
331.15 | 70.63 | 91.70 | 109.89 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.19 | — | 0.11 | 0.39 | |
Average Payables |
1.30 | 2.16 | 0.74 | 1.03 | |
Average Assets |
269.01 | 148.61 | 170.26 | 187.23 | |
Average Common Equity |
248.27 | 128.32 | 148.31 | 165.11 |
Columns are period end dates